Status:
COMPLETED
Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent
Lead Sponsor:
Pfizer
Conditions:
Renal Cell Carcinoma
Eligibility:
All Genders
18-75 years
Brief Summary
The Sutent® Observational Study is being proposed to assess the real-world usage patterns and effectiveness and tolerability of treatment of Indian patients with advanced renal cell cancer with Sutent...
Detailed Description
The assignment of the patient to Sutent® treatment is not decided in advance by this noninterventional study protocol, but falls within current practice. The decision to prescribe Sutent® is clearly n...
Eligibility Criteria
Inclusion
- Patients with advanced renal cell cancer
- Treatment naïve or cytokine refractory
Exclusion
- Patients presenting with a known hypersensitivity to Sunitinib or its metabolites
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00836745
Start Date
March 1 2009
End Date
July 1 2012
Last Update
December 20 2013
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Jaipur, Jaipur, India, 302006
2
Pfizer Investigational Site
Bangalore, Karnataka, India, 560 027
3
Pfizer Investigational Site
Mumbai, Maharashtra, India, 400014
4
Pfizer Investigational Site
New Delhi, National Capital Territory of Delhi, India, 110 085